Transcriptional studies revealed that in glioblastoma tumors, classified according to the isocitrate dehydrogenase (IDH) mutation status, BCAT1 expression was significantly higher in IDHwt gliomas while in IDHmut gliomas it was suppressed [99]. The gene discussed is IDH3A; the disease is central nervous system cancer.